Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 3/02/05 → 1/02/07 |
Funding
- ARC - Australian Research Council: A$104,450.00
- GBS Venture Partners Pty Ltd: A$90,000.00
DsbA: A target for the design of drug candidates as selective inhibitors of oxidative protein folding in Gram-negative bacteria
- Scanlon, Martin (Primary Chief Investigator (PCI))
- Charman, William (Chief Investigator (CI))
- Sakellaris, Haralambos (Chief Investigator (CI))
- Farrell, Leigh (Partner Investigator (PI))
Project: Research